Clinical Trial: A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841925) titled 'A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors' on Sept. 20.

Brief Summary: This Phase Ib/II study is a clinical study to explore the efficacy and safety of BL-M08D1 for injection in patients with locally advanced or metastatic melanoma and other solid tumors.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Melanoma Solid Tumors

Intervention: DRUG: BL-M08D1

Administration by intravenous infusion for a cycle of 3 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.

Published by HT Digital Content Services with p...